Literature DB >> 11595834

p73 in apoptosis.

T Stiewe1, B M Pützer.   

Abstract

The TP53 tumour-suppressor gene belongs to a family that includes the two recently identified homologues TP63 and TP73. Overexpression of p73 can activate typical p53-responsive genes and induce apoptosis like p53. In addition, activation of p73 has been implicated in apoptotic cell death induced by aberrant cell proliferation and some forms of DNA-damage. These data together with the localization of TP73 on chromosome 1p36, a region frequently deleted in a variety of human cancers, led to the hypothesis that p73 has tumour suppressor activity just like p53. However, despite its proapoptotic activity in vitro, the lack of tumour-formation in p73 knock-out mice and primary human tumour data demonstrating overexpression of wild-type p73 currently argue against p73 being a classical tumour suppressor. Interestingly, in contrast to TP53, TP73 gives rise to a complex pattern of pro- and antiapoptotic p73 isoforms generated by differential splicing and alternative promoter usage. Therefore further insight into the function and regulation of these structurally and functionally diverse p73 proteins is needed to elucidate the role of TP73 for apoptosis and human tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595834     DOI: 10.1023/a:1012433522902

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  17 in total

1.  Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs.

Authors:  Caroline Goujon; Antoine Rebendenne; Priyanka Roy; Boris Bonaventure; Ana Chaves Valadao; Lowiese Desmarets; Yves Rouillé; Marine Tauziet; Mary Arnaud-Arnould; Donatella Giovannini; Yenarae Lee; Peter DeWeirdt; Mudra Hegde; Francisco Garcia de Gracia; Joe McKellar; Mélanie Wencker; Jean Dubuisson; Sandrine Belouzard; Olivier Moncorgé; John Doench
Journal:  Res Sq       Date:  2021-05-27

Review 2.  Telomeres, lifestyle, cancer, and aging.

Authors:  Masood A Shammas
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-01       Impact factor: 4.294

Review 3.  Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.

Authors:  Jagannath Pal; Jason S Gold; Nikhil C Munshi; Masood A Shammas
Journal:  Transl Res       Date:  2013-10-01       Impact factor: 7.012

Review 4.  Mechanisms, function and clinical applications of DNp73.

Authors:  Cuixia Di; Lina Yang; Hong Zhang; Xiaofei Ma; Xin Zhang; Chao Sun; Hongyan Li; Shuai Xu; Lizhe An; Xun Li; Zhongtian Bai
Journal:  Cell Cycle       Date:  2013-06-13       Impact factor: 4.534

5.  Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.

Authors:  M A Shammas; H Koley; R C Bertheau; P Neri; M Fulciniti; P Tassone; S Blotta; A Protopopov; C Mitsiades; R B Batchu; K C Anderson; A Chin; S Gryaznov; N C Munshi
Journal:  Leukemia       Date:  2008-05-01       Impact factor: 11.528

6.  DeltaNp73 regulates neuronal survival in vivo.

Authors:  Fadel Tissir; Aurélia Ravni; Younès Achouri; Dieter Riethmacher; Gundela Meyer; Andre M Goffinet
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-10       Impact factor: 11.205

7.  Diallyl disulfide enhances carbon ion beams-induced apoptotic cell death in cervical cancer cells through regulating Tap73 /ΔNp73.

Authors:  Cuixia Di; Chao Sun; Hongyan Li; Jing Si; Hong Zhang; Lu Han; Qiuyue Zhao; Yang Liu; Bin Liu; Guoying Miao; Lu Gan; Yuanyuan Liu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 8.  Gene therapy in pancreatic cancer.

Authors:  Si-Xue Liu; Zhong-Sheng Xia; Ying-Qiang Zhong
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

9.  NSP 5a3a: a potential novel cancer target in head and neck carcinoma.

Authors:  Luca D'agostino; Antonio Giordano
Journal:  Oncotarget       Date:  2010-10

10.  Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential.

Authors:  Masood A Shammas; Hemanta Koley; Ramesh B Batchu; Robert C Bertheau; Alexei Protopopov; Nikhil C Munshi; Raj K Goyal
Journal:  Mol Cancer       Date:  2005-07-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.